Together, this powerful cocktail will have you at peak performance
It is still the only oral GLP-1 on the market for type 2 diabetes, and in 2025, semaglutide in a pill was approved in the US as first oral GLP-1 for weight management
FDA Approved Indications Type 2 Diabetes (Mounjaro): Approved for use as an adjunct to diet and exercise to improve glycemic control
J Invest Dermatol (2013) 133:37785
With Australian Bodycare by your side, you can confidently manage your skincare needs, feeling supported every step of the way on your journey.
GLP-1 agonists are widely prescribed in the private sector, usually with no face-to-face interaction, followed by a brief letter to the GP to inform them that their patient is taking this medication